Pelvic organ prolapse (POP) represents a highly prevalent condition among women, particularly following childbirth and during aging, with recurrence rates following surgical intervention posing significant clinical challenges that substantially increase treatment difficulty and healthcare burden. Despite advances in surgical techniques, the molecular mechanisms underlying POP recurrence remain poorly understood, limiting the development of targeted therapeutic strategies. A research study by Yaqian Li and colleagues employed single-cell RNA sequencing technology to conduct comprehensive comparative analysis of vaginal fibroblasts, smooth muscle cells, and macrophages between recurrent and primary POP patients, revealing substantial molecular heterogeneity that provides novel insights into the cellular and molecular drivers of POP recurrence.

Congenital heart defects (CHD) represent the most common congenital malformations globally and constitute a leading cause of neonatal mortality, with early maternal risk factors playing significant roles in their development. A comprehensive systematic review and meta-analysis by Zihan Suo and colleagues investigated the relationships between various maternal factors during the first trimester and the risk of CHD in offspring, providing robust evidence for public health strategies aimed at reducing CHD incidence. The study protocol was registered on PROSPERO (CRD42023476855), ensuring methodological transparency and rigor.

Chronic diabetic ulcers represent one of the most challenging complications in modern healthcare, affecting over 131 million people worldwide and generating approximately $755 billion in annual healthcare costs. These wounds are characterized by high amputation and mortality rates, creating an urgent need for deeper understanding of their pathophysiology. Immune cells serve as indispensable orchestrators of wound healing, yet existing literature often overlooks the temporal heterogeneity of immune cell subsets in diabetic ulcers. A comprehensive review by Yi Ru and colleagues addresses this critical gap by systematically examining the roles and characteristics of diverse immune cell populations throughout different stages of diabetic wound healing.

Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating remarkable efficacy in targeting pathogenic B-cell lineages with unprecedented specificity. Originally developed for B cell malignancies, this innovative immunotherapy has recently shown extraordinary potential in treating various autoimmune diseases by depleting autoreactive B cells and effectively resetting the immune system. The review by Qi Li and colleagues provides a comprehensive examination of the progression, clinical applications, challenges, and future directions of B cell-targeted CAR-T therapy across multiple autoimmune conditions.

Extensive bone defects pose substantial clinical challenges, frequently resulting in severe functional impairment and diminished quality of life for patients. Conventional therapeutic approaches, including autografts and allografts, remain widely utilized despite significant drawbacks such as donor site morbidity, limited availability, and potential immunogenic responses. Consequently, tissue engineering has emerged as an increasingly attractive alternative strategy. Bioceramic bone repair materials offer dual functionality by providing essential mechanical support while delivering bioactive properties that facilitate defect healing. A critical aspect of their therapeutic efficacy lies in their capacity to modulate the immune microenvironment, thereby promoting cellular behaviors and signaling pathways that favor bone regeneration. These immunoregulatory effects prove instrumental throughout the entire bone repair process and largely determine the ultimate success of regenerative outcomes. For example, hydroxyapatite demonstrates the ability to induce macrophage polarization toward the M2 phenotype, generating anti-inflammatory effects that enhance bone tissue repair. A comprehensive review published in Frontiers of Medicine systematically examines recent progress in bioceramic research for bone tissue engineering, encompassing material classification, immunomodulatory mechanisms, contemporary fabrication methodologies, and clinical translation status, with the objective of informing future investigations and improved therapeutic strategies.

Discovery reveals how drug-resistant tumours can shift into a state that responds better to chemotherapy.

Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular underpinnings beyond genetic predisposition. Epigenetic modifications, particularly methylation changes affecting DNA, proteins, and RNA, have emerged as critical regulators of gene expression implicated in cardiac pathophysiology. These heritable yet reversible chemical alterations govern chromatin architecture, transcriptional activity, and post-transcriptional processing without changing underlying nucleotide sequences. Within the spectrum of cardiovascular pathology—including ischemic heart disease, cardiac hypertrophy, heart failure, and atherosclerosis—dysregulated methylation patterns contribute substantially to disease initiation, progression, and phenotypic manifestation. Understanding the distinct and convergent roles of these three major methylation modalities offers promising avenues for developing novel diagnostic biomarkers and targeted therapeutic interventions that could transform precision medicine in cardiology.

Deep tissue injury (DTI) is a serious condition primarily triggered by prolonged mechanical loading rather than short-term excessive force. Cyclic force stimulation has been shown to enhance cellular protection; however, the biomechanical mechanisms underlying tissue and cellular responses to such stimulation remain poorly understood.

Circulating tumor cells (CTCs) are cancerous cells that break away from the primary tumor, enter the bloodstream, and travel to another part of the body. Research into CTCs, particularly their biological phenotypes and molecular mechanisms, has provided critical insights into metastasis and potential therapeutic targets.